This is in sharp contrast to GSH, which can enter cells only slowly via specific transporters
It mimics a hormone that slows down stomach emptying, keeping people fuller longer, and tells the brain to be satisfied with less food
Food and Drug Administration (FDA) include semaglutide (sold as Ozempic and Wegovy), liraglutide (Saxenda and Victoza), and tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist
doi: 10.1017/S0007114509990535 100
It stimulates lipolysis and inhibits lipogenesis without the growth-promoting effects of full-length hGH, making it a highly targeted tool for adipose tissue and metabolic research
Despite growing interest, none of these compounds are currently approved medicines in the United Kingdom